Fig. 6
Fluorouracil treatment of MAF-928_XC. (A) Sagittal plane, T2 scans at 4 and 8 weeks post initiation of 5FU treatment. Mice received either vehicle or 30 mg/kg 5FU i.p. once weekly for 7 total doses. Blue arrow indicates posterior fossa disease; yellow arrow indicates metastases. (B) Quantification of tumor volume at each scan time. Blue denotes vehicle treated mice; red denotes 5FU treated mice. (C) Survival time of vehicle (blue), 5FU (red) treated mice.

Fluorouracil treatment of MAF-928_XC. (A) Sagittal plane, T2 scans at 4 and 8 weeks post initiation of 5FU treatment. Mice received either vehicle or 30 mg/kg 5FU i.p. once weekly for 7 total doses. Blue arrow indicates posterior fossa disease; yellow arrow indicates metastases. (B) Quantification of tumor volume at each scan time. Blue denotes vehicle treated mice; red denotes 5FU treated mice. (C) Survival time of vehicle (blue), 5FU (red) treated mice.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close